Welcome to the working week. We hope the weekend was refreshing and restful, although now, of course, the routine resumes. To prepare, we are brewing the mandatory cup of stimulation. Meanwhile, we would like to note that we are hosting a webinar on Thurs., Dec. 9 about the FDA's Accelerated Approval process (please look here). Please join us. And now, the news of the world. Have a great day and if you run into Jeff Kindler, please send our regards...
Celgene Stock Hurt By Revlimid Cancer Data (TheStreet)
Elan Replaces Martin With Former Glaxo CEO Ingram (Bloomberg News)
FDA Delays Decision On Benlysta Lupus Med (Associated Press)
China To Lead Innovation By 2020: AstraZeneca Survey (PharmaTimes)